Pulmatrix, Inc.
Pulmatrix, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 3 | 4 | 5 | 6 | 8 | 10 | 11 | 12 | 16 | 19 | 21 | |||||
Assets Current | |||||||||||||||||
Assets Current | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 11 | 16 | 18 | 21 | 23 | |||||
Accounts Receivable Net Current | - | - | - | - | - | 0 | - | 0 | 1 | 1 | 1 | 1 | |||||
Restricted Cash Current | 1 | 1 | - | - | - | - | - | - | 1 | - | - | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | |||||
Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | 10 | 10 | 11 | |||||
Other Assets Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 12 | 16 | 30 | 34 | 37 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | |||||
Accrued Liabilities And Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 3 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Deferred Revenue Noncurrent | - | - | - | - | - | - | - | - | - | - | 4 | 4 | |||||
Liabilities | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 11 | 16 | 17 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | 8 | 8 | 8 | |||||
Deferred Revenue Current | - | - | - | - | - | - | - | - | 0 | 0 | 1 | 1 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 1 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Stockholders Equity | 3 | 4 | 4 | 5 | 6 | 7 | 9 | 11 | 13 | 19 | 18 | 20 | |||||
Additional Paid In Capital | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 306 | 305 | |||||
Retained Earnings Accumulated Deficit | -305 | -303 | -302 | -301 | -301 | -299 | -297 | -295 | -293 | -287 | -288 | -286 | |||||
Liabilities And Stockholders Equity | 3 | 4 | 4 | 5 | 6 | 8 | 10 | 12 | 16 | 30 | 34 | 37 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Shares Outstanding | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.40% | 37.60% | 36.00% | - | - | - | - | - | - | - | - | - |
| 2025 | 36.33% | 0.14% | -18.22% | -7.16% | -16.57% | -8.85% | 4.53% | -12.07% | -51.29% | -14.43% | -56.70% | -57.04% |
| 2024 | 5.06% | 8.43% | 17.98% | -16.67% | -12.50% | -11.25% | 223.90% | 212.20% | 255.12% | -27.71% | -17.00% | 19.01% |
| 2023 | - | - | - | - | - | - | 9.19% | 0.54% | -1.89% | 13.71% | 9.14% | 9.60% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 4.70 | 4.96 | 12.55 | 19.97 | 11.21 | 8.90 | 10.68 | 19.40 | 6.33 | 5.59 | 5.33 | 5.24 | |||||
| Quick Ratio | 4.16 | 4.45 | 12.43 | 19.25 | 10.63 | 8.55 | 10.25 | 18.31 | 5.84 | 5.37 | 5.14 | 5.04 | |||||
| Working Capital | 2.55M | 3.58M | 3.80M | 4.72M | 5.59M | 7.14M | 8.99M | 10.86M | 13.17M | 14.44M | 16.93M | 18.80M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.27 | 0.25 | 0.09 | 0.05 | 0.10 | 0.13 | 0.11 | 0.05 | 0.19 | 0.60 | 0.89 | 0.85 | |||||
| Interest Coverage TTM | - | - | -97.53 | -49.31 | -35.26 | -34.33 | -20.91 | -17.13 | -16.12 | -11.69 | -17.00 | -19.45 | |||||
| Debt Ratio | 0.21 | 0.20 | 0.08 | 0.05 | 0.09 | 0.11 | 0.10 | 0.05 | 0.16 | 0.37 | 0.47 | 0.46 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.71 | 0.57 | 0.10 | 0.36 | 0.23 | 0.30 | 0.35 | 0.19 | 0.16 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | 55.67 | - | 28.06 | 27.43 | 20.46 | 55.67 | 37.18 | |||||
| Receivables Turnover TTM | - | - | - | - | - | 6.56 | - | 13.01 | 13.31 | 17.84 | 6.56 | 9.82 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.10 | -1.24 | -1.41 | -1.70 | -2.17 | -3.34 | -2.62 | -2.64 | -2.97 | -2.42 | -3.87 | -4.45 | |||||
| Free Cash Flow Per Share TTM | -1.07 | -1.28 | -1.49 | -1.64 | -2.19 | -2.75 | -3.04 | -3.33 | -3.71 | -4.00 | -4.56 | -5.31 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | -105.52% | -127.98% | -643.26% | -125.07% | -178.61% | -161.55% | -80.52% | -201.97% | -260.48% | |||||
| Net Profit Margin TTM | - | - | - | -105.64% | -126.80% | -634.67% | -122.46% | -171.85% | -154.77% | -75.73% | -193.49% | -251.42% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -100.00% | -100.00% | -100.00% | 4.79% | -10.73% | -83.56% | 6.96% | -13.09% | 6.41% | 82.28% | 20.21% | 28.05% | |||||
| Net Income Growth (1Y) | -49.39% | -62.88% | -46.00% | -35.58% | -26.87% | 37.79% | -32.31% | -40.59% | -38.15% | -51.68% | -25.03% | -25.60% | |||||
| EPS Growth (1Y) | -49.39% | -62.88% | -46.00% | -35.58% | -26.87% | 37.79% | -32.31% | -40.59% | -38.15% | -51.70% | -29.22% | -29.15% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.55 | -1.04 | -1.58 | -2.85 | -3.18 | -2.00 | -2.67 | -0.81 | -0.65 | -0.72 | -0.48 | -0.46 | |||||
| P/B TTM | 2.43 | 1.31 | 2.14 | 3.75 | 4.50 | 3.40 | 2.85 | 0.72 | 0.53 | 0.34 | 0.38 | 0.37 | |||||
| P/S TTM | - | - | - | 3.01 | 4.03 | 12.66 | 3.27 | 1.39 | 1.01 | 0.55 | 0.93 | 1.15 | |||||
| Market Cap | 6.21M | 4.71M | 8.14M | 17.75M | 25.20M | 24.32M | 25.49M | 7.82M | 7.05M | 6.39M | 6.79M | 7.41M | |||||
| Enterprise Value | 4.04M | 1.39M | 4.06M | 12.96M | 19.38M | 16.62M | 15.97M | -2.97M | -5.33M | -9.91M | -12.38M | -13.92M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -3.91M | -4.69M | -5.43M | -5.99M | -8.02M | -10.05M | -11.11M | -12.17M | -13.57M | -14.61M | -16.66M | -19.40M | |||||
| Net Debt | -2.17M | -3.32M | -4.09M | -4.79M | -5.83M | -7.71M | -9.52M | -10.78M | -12.38M | -16.30M | -19.17M | -21.34M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Pulmatrix, Inc. (PULM) — SEC Financial Statements & Analysis
Pulmatrix, Inc. (PULM) is a pharmaceutical preparations company, incorporated in DE. Pulmatrix, Inc. trades on Nasdaq as: PULM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Pulmatrix, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.27x, a Price-to-Sales (P/S) ratio of 3.01x (TTM), a Price-to-Book (P/B) ratio of 2.43x (TTM), at a market cap of $6.21M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- 0.27x
- P/S TTM
- 3.01x
- P/B TTM
- 2.43x
- Market Cap
- $6.21M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pulmatrix, Inc. in?
Pulmatrix, Inc. (PULM) operates in the Pharmaceutical Preparations industry.
What is PULM's market cap?
Pulmatrix, Inc. (PULM) has a market capitalization of $6.21M as of 2026-06-30.
What exchange does PULM trade on?
Pulmatrix, Inc. (PULM) trades on the Nasdaq.
Where is Pulmatrix, Inc. incorporated?
Pulmatrix, Inc. is incorporated in DE.